Allscripts (MDRX) Tops Q2 EPS by 6c
Allscripts (NASDAQ: MDRX) reported Q2 EPS of $0.23, $0.06 better than the analyst estimate of $0.17. Revenue for the quarter came in at $374 million versus the consensus estimate of $373.45 million.
For earnings history and earnings-related data on Allscripts (MDRX) click here.
